JT
Geneva Biotech Pipeline
| Drug | Indication | Phase |
|---|---|---|
| GB-007 | Targets a GPCR (indication unspecified) | Preclinical |
Leadership Team at Geneva Biotech
DD
Dr. Daniel Fitzgerald
CEO
PI
Professor Imre Berger
Scientific Co-Founder
PC
Professor Christiane Berger-Schaffitzel
Scientific Co-Founder
DS
Dr. Sanja Narancic
Computational Chemistry
ST
Sonya Timmerman
Finance / Managing Director USA
AD
Alicia Del Pierro
Sales and Marketing